DuPont Merck
Executive Summary
ICN Pharmaceuticals' Group VP and General Manager Richard Dolighan named president of DuPont Merck's radiopharmaceutical division. He replaces Kenneth Kasses, who left in September to become president and CEO of Genta. Dolighan previously worked for Canadian subsidiaries of Burroughs Wellcome and Bristol-Myers Squibb...